Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 16
More JCP Articles
Educational Activity
Emerging Therapies for Attention-Deficit/Hyperactivity Disorder
August 9, 2023
While patients with ADHD today still face numerous unmet needs, a number of newer pharmacologic agents and devices with potential advantages over traditional therapies have emerged and gained regulatory…
Clinical and Practical Psychopharmacology
Using Percentiles to Understand Standardized Mean Difference as a Measure of Effect Size
August 7, 2023
Chittaranjan Andrade, MD, explains the use of SMDs as a measure of effect size. A recent meta-analysis of the effect of ChEIs on hallucinations and delusions in Alzheimer and…
Clinical and Practical Psychopharmacology
ChEIs for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Significant Benefits?
July 31, 2023
Chittaranjan Andrade, MD, takes a closer look at a recent meta-analysis indicating that donepezil, rivastigmine, and galantamine lessened both delusions and hallucinations in Alzheimer disease and Parkinson disease.
Original Research
Race, Ethnicity, and ED Disposition for Mental Health Visits
July 26, 2023
Black patients, especially Black male patients, are overrepresented in inpatient psychiatry. This study examined biases in admission rates among Black patients and, specifically, Black male patients with or without…
